EUVIMEDEUVIMED entdecken
Crossref

Simultaneous Cholesterol Reduction and cGAS-STING Pathway Amplification: A Novel Enzyme Cascade Strategy against Tumor Resistance

Chenxin Liu, Jialing Guo, Jieke Zhang, Ligang Wu, Xiaodi Zhang, Weihua Fan, Bin Du iD

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c04596 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Chenxin Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhengzhou University, 100 Science Road, Zhengzhou, Henan 450001, China. Hauptthemen laut MEDLINE: Doxorubicin, Cholesterol, Drug Resistance, Neoplasm, Nucleotidyltransferases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug resistance remains a significant challenge in cancer therapy, and current strategies typically involve the use of P-glycoprotein (P-gp) inhibitors. Unfortunately, the rigid surface of drug-resistant cancer cell membranes and the immunosuppressive tumor microenvironment severely limit the therapeutic efficacy. Here, we report a novel nanoparticle platform named DOX@CM@M, which can efficiently reverse tumor resistance through cholesterol depletion, while robustly enhancing antitumor effects by activating innate immunity. The platform utilizes Fe/Mn hybrid metal-organic frameworks (MOF) to encapsulate doxorubicin (DOX) and cholesterol oxidase (COD), and further modifies with the cancer cell membrane (CCM) to enhance tumor targeting. The acidic and GSH-rich environment within tumor cells provides the possibility of responsive degradation. Based on the release of the natural enzyme COD and the peroxidase-like properties of Fe3+/Mn2+, cholesterol is effectively depleted in a "turning foe into friend" manner, promoting the effective accumulation of the chemotherapy model drug DOX and reversing tumor resistance. Notably, the activation of the cGAS-STING pathway by DOX can be further amplified by Mn2+, synergistically enhancing the innate immune response. In vivo results demonstrate that DOX@CM@M nanoparticles (NPs) significantly inhibit tumor growth, reduce cholesterol content, and promote DC maturation, providing a new approach to reversing tumor resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinCholesterolDrug Resistance, NeoplasmNucleotidyltransferasesMembrane ProteinsAnimalsMiceHumansNanoparticlesCell Line, TumorMetal-Organic FrameworksCholesterol OxidaseImmunity, InnateSignal TransductionSTING ProteinCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Stichwörter der Autor:innen

cGAS-STING pathwaycholesteroldrug resistanceimmunotherapymetal−organic frame (MOF)

Substanzen

DoxorubicinCholesterolNucleotidyltransferasesMembrane ProteinsMetal-Organic FrameworksCholesterol OxidaseSTING1 protein, humanSTING ProteincGAS protein, humanCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Zhengzhou University, 100 Science Road, Zhengzhou, Henan 450001, China.
  • Henan Key Laboratory of Nanomedicine for Targeting Diagnosis and Treatment, 100 Science Road, Zhengzhou, Henan 450001, China.

ORCID-Profile: Bin Du

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, C., Guo, J., Zhang, J., Wu, L., Zhang, X., Fan, W., & Du, B. (2025). Simultaneous Cholesterol Reduction and cGAS-STING Pathway Amplification: A Novel Enzyme Cascade Strategy against Tumor Resistance. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c04596

Vancouver

Liu C, Guo J, Zhang J, Wu L, Zhang X, Fan W, et al. Simultaneous Cholesterol Reduction and cGAS-STING Pathway Amplification: A Novel Enzyme Cascade Strategy against Tumor Resistance. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c04596

BibTeX
@article{Liu2025,
  author = {Liu, Chenxin and Guo, Jialing and Zhang, Jieke and Wu, Ligang and Zhang, Xiaodi and Fan, Weihua and Du, Bin},
  title = {Simultaneous Cholesterol Reduction and cGAS-STING Pathway Amplification: A Novel Enzyme Cascade Strategy against Tumor Resistance},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c04596}
}
Kostenlos starten →